Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLCverified

HIK.L

Price:

$1901

Market Cap:

$5.61B

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including anti-infective, cardiovasc...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2005-11-01

Stock Exchange

LSE

Ticker

HIK.L

The Enterprise Value as of September 2024 (TTM) for Hikma Pharmaceuticals PLC (HIK.L) is 6.64B

According to Hikma Pharmaceuticals PLC’s latest financial reports and current stock price. The company's current Enterprise Value is 6.64B. This represents a change of 10.72% compared to the average of 5.99B of the last 4 quarters.

Hikma Pharmaceuticals PLC (HIK.L) Historical Enterprise Value (quarterly & annually)

How has HIK.L Enterprise Value performed in the past?

The mean historical Enterprise Value of Hikma Pharmaceuticals PLC over the last ten years is 6.32B. The current 6.64B Enterprise Value has changed 10.41% with respect to the historical average. Over the past ten years (40 quarters), HIK.L's Enterprise Value was at its highest in in the December 2020 quarter at 8.62B. The Enterprise Value was at its lowest in in the December 2010 quarter at 101.13M.

Quarterly (TTM)
Annual

Average

6.32B

Median

6.26B

Minimum

4.14B

Maximum

8.72B

Hikma Pharmaceuticals PLC (HIK.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Hikma Pharmaceuticals PLC Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 52.21%

Maximum Annual Enterprise Value = 8.72B

Minimum Annual Increase = -32.58%

Minimum Annual Enterprise Value = 4.14B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20236.02B15.48%
20225.21B-29.19%
20217.36B-15.68%
20208.72B31.64%
20196.63B17.73%
20185.63B35.91%
20174.14B-32.58%
20166.14B-11.24%
20156.92B8.40%
20146.38B52.21%

Hikma Pharmaceuticals PLC (HIK.L) Average Enterprise Value

How has HIK.L Enterprise Value performed in the past?

The current Enterprise Value of Hikma Pharmaceuticals PLC (HIK.L) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

6.19B

5-year avg

6.79B

10-year avg

6.32B

Hikma Pharmaceuticals PLC (HIK.L) Enterprise Value vs. Peers

How is HIK.L’s Enterprise Value compared to its peers?

Hikma Pharmaceuticals PLC’s Enterprise Value is less than Intertek Group plc (9.08B), less than Mondi plc (8.97B), less than Halma plc (10.58B), less than Bunzl plc (14.09B), less than Smith & Nephew plc (16.47B),

CompanyEnterprise ValueMarket cap
9.08B$8.07B
8.97B$6.20B
10.58B$9.93B
14.09B$12.07B
16.47B$10.07B

Build a custom stock screener for Hikma Pharmaceuticals PLC (HIK.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hikma Pharmaceuticals PLC using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hikma Pharmaceuticals PLC (HIK.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hikma Pharmaceuticals PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Hikma Pharmaceuticals PLC's Enterprise Value?

What is the highest Enterprise Value for Hikma Pharmaceuticals PLC (HIK.L)?

What is the 3-year average Enterprise Value for Hikma Pharmaceuticals PLC (HIK.L)?

What is the 5-year average Enterprise Value for Hikma Pharmaceuticals PLC (HIK.L)?

How does the current Enterprise Value for Hikma Pharmaceuticals PLC (HIK.L) compare to its historical average?